This induces acetaldehyde metabolic dysfunction and drives tumor metabolic reprogramming, with SAE1-mediated KLF9 inhibition correlating positively with poor prognosis and metastatic risk in HCC patients (31). The gene discussed is SAE1; the disease is neoplasm.